Freedman, S., Hercinovic, A., Wallace, D. K., Kraker, R., Li, Z., Bhatt, A., et al. (2022). Low- and Very Low-Dose Bevacizumab for Retinopathy of Prematurity: Reactivations, Additional Treatments, and 12-Month Outcomes. Ophthalmology, 129(10), 1120-1128. 10.1016/j.ophtha.2022.05.019(Original work published 2022)
Wallace, D. K., Hercinovic, A., Freedman, S., Crouch, E., Bhatt, A., Hartnett, E., et al. (2023). Ocular and developmental outcomes of a dosing study of bevacizumab for retinopathy of prematurity. Journal Of The American Association For Pediatric Ophthalmology And Strabismus, 27(1), 10.e1-10.e8. 10.1016/j.jaapos.2022.11.020(Original work published 2023)
